Evidence map›Paper›PMID 36861665›Full record

ArticleJournal of biomedical materials research. Part A2023

Elastin-like protein hydrogels with controllable stress relaxation rate and stiffness modulate endothelial cell function.

Mahdis Shayan, Michelle S Huang, Renato Navarro, Gladys Chiang, Caroline Hu, Beu P Oropeza, Patrik K Johansson, Riley A Suhar, Abbygail A Foster, Bauer L LeSavage and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Matrix Stiffness-Mediated DNA Methylation in Endothelial Cells.Cellular and molecular bioengineering · 2025
    Article
  11. Article
  12. Article
  13. Contribution of the ELRs to the development of advancedFrontiers in bioengineering and biotechnology · 2024
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Mahdis ShayanDepartment of Cardiothoracic Surgery, Stanford University, Palo Alto, California, USA.
Michelle S HuangDepartment of Chemical Engineering, Stanford University, Palo Alto, California, USA.
Renato NavarroDepartment of Materials Science & Engineering, Stanford University, Palo Alto, California, USA.
Gladys ChiangCenter for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
Caroline HuCenter for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
Beu P OropezaDepartment of Cardiothoracic Surgery, Stanford University, Palo Alto, California, USA.
Patrik K JohanssonGeballe Laboratory for Advanced Materials, Stanford University, Palo Alto, California, USA.
Riley A SuharDepartment of Materials Science & Engineering, Stanford University, Palo Alto, California, USA.
Abbygail A FosterDepartment of Materials Science & Engineering, Stanford University, Palo Alto, California, USA.
Bauer L LeSavageDepartment of Bioengineering, Stanford University, Palo Alto, California, USA.
Maedeh ZamaniDepartment of Cardiothoracic Surgery, Stanford University, Palo Alto, California, USA.
Annika EnejderGeballe Laboratory for Advanced Materials, Stanford University, Palo Alto, California, USA.
Julien G RothInstitute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
Sarah C HeilshornThe Stanford Cardiovascular Institute, Stanford University, Palo Alto, California, USA.
Ngan F HuangDepartment of Cardiothoracic Surgery, Stanford University, Palo Alto, California, USA.ORCID 0000-0003-2298-6790
Palo Alto University · USVA Palo Alto Health Care System · USCalifornia Institute for Regenerative Medicine · US

Funding

Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia: Sex Differences Administrative SupplementR01HL127113 · NHLBI · STANFORD UNIVERSITY · PI HUANG, NGAN F. · 2016 to 2020
$2.5M
Injectable Hydrogels to Deliver Gene Therapy for Myocardial InfarctR01HL151997 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2020 to 2023
$1.7M
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cellsR01HL142718 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, HUANG, NGAN F. · 2018 to 2021
$1.6M
Injectable Hydrogels to Protect Transplanted Cells from HypoxiaR01EB027666 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, PLANT, GILES · 2019 to 2022
$1.4M
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cellsR01EB027171 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2019 to 2022
$1.4M
Combinatorial matrix-mimetic recombinant proteins as engineered nerve guidance conduitsR21NS114549 · NINDS · STANFORD UNIVERSITY · PI GEORGE, PAUL, HASTIE, TREVOR J. · 2020 to 2020
$436k
Muscle Stem Cell Therapy for Volumetric Muscle LossI01RX001222 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI HUANG, NGAN F. · 2014 to 2023
–
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle LossI01BX004259 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI Ngan F. Huang · 2019 to 2026
–
BLRD VA I01 BX002310BLRD VA I01 BX004259NHLBI NIH HHS R01 HL127113NHLBI NIH HHS R01 HL142718NHLBI NIH HHS R01 HL151997NIBIB NIH HHS R01 EB027171NIBIB NIH HHS R01 EB027666NINDS NIH HHS R21 NS114549RRD VA I01 RX001222
6 · The paper itself

Abstract

Mechanical cues from the extracellular matrix (ECM) regulate vascular endothelial cell (EC) morphology and function. Since naturally derived ECMs are viscoelastic, cells respond to viscoelastic matrices that exhibit stress relaxation, in which a cell-applied force results in matrix remodeling. To decouple the effects of stress relaxation rate from substrate stiffness on EC behavior, we engineered elastin-like protein (ELP) hydrogels in which dynamic covalent chemistry (DCC) was used to crosslink hydrazine-modified ELP (ELP-HYD) and aldehyde/benzaldehyde-modified polyethylene glycol (PEG-ALD/PEG-BZA). The reversible DCC crosslinks in ELP-PEG hydrogels create a matrix with independently tunable stiffness and stress relaxation rate. By formulating fast-relaxing or slow-relaxing hydrogels with a range of stiffness (500-3300 Pa), we examined the effect of these mechanical properties on EC spreading, proliferation, vascular sprouting, and vascularization. The results show that both stress relaxation rate and stiffness modulate endothelial spreading on two-dimensional substrates, on which ECs exhibited greater cell spreading on fast-relaxing hydrogels up through 3 days, compared with slow-relaxing hydrogels at the same stiffness. In three-dimensional hydrogels encapsulating ECs and fibroblasts in coculture, the fast-relaxing, low-stiffness hydrogels produced the widest vascular sprouts, a measure of vessel maturity. This finding was validated in a murine subcutaneous implantation model, in which the fast-relaxing, low-stiffness hydrogel produced significantly more vascularization compared with the slow-relaxing, low-stiffness hydrogel. Together, these results suggest that both stress relaxation rate and stiffness modulate endothelial behavior, and that the fast-relaxing, low-stiffness hydrogels supported the highest capillary density in vivo.

Indexed as

ElastinHydrogelsAnimalsBiocompatible MaterialsEndothelial CellsExtracellular MatrixMiceBiocompatible MaterialsElastinHydrogelsendothelial cellhydrogelstiffnessstress relaxationvascular sprouting

Identifiers

PMID36861665
PMCPMC10159914
OpenAlexW4322757828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.